Bonus round.

For the superstars out there who make it to an unresectable thymic tumor case on oral boards, here is a phase 2 trial demonstrating an impressive response rate of 86% with 2 Gy x 30 = 60 Gy using IMRT concurrent to cisplatin and etoposide. | Fan, Int J Radiat Oncol Biol Phys 2020